NanoString announced new products to advance COVID-19 disease research
On Jun. 16, 2020, NanoString Technologies announced the availability of new solutions to study the immune response in…
Biotechnology | COVID-19 | Therapeutics | WHO
WHO announced preliminary results about dexamethasone use in treating critically ill COVID-19 patients
On Jun. 16, 2020, the World Health Organization (WHO) announced that initial clinical trial results from the United…
Lilly begans phase 3 clinical trial with baricitinib for hospitalized COVID-19 patients
On Jun. 15, 2020, Eli Lilly announced that the first patient has been enrolled in a Phase 3…
Catalent announced agreement with AstraZeneca to manufacture COVID-19 vaccine candidate
On Jun. 15, 2020, Catalent announced that it will provide vial filling and packaging capacity to AstraZeneca at…
Immunic announced first patients dosed in its phase 2, CALVID-1 clinical trial of IMU-838 in COVID-19
On Jun. 15, 2020, Immunic announced dosing of the first patients in its phase 2, CALVID-1 clinical trial…
Cleveland Clinic researchers developed first model to predict likelihood of testing positive for COVID-19 and outcomes from the disease
On Jun. 15, 2020, Cleveland Clinic researchers announced they had developed the worldﾒs first risk prediction model for…
The FDA warned of newly discovered potential drug interaction that may reduce effectiveness of COVID-19 treatment
On Jun. 15, 2020, the U.S. Food and Drug Administration (FDA) warned health care providers about a newly…
The FDA revoked Emergency Use Authorization for chloroquine and hydroxychloroquine
On Jun. 15, 2020, the U.S. Food and Drug Administration (FDA) revoked the emergency use authorization (EUA) that…
NIH launched analytics platform to harness nationwide COVID-19 patient data to speed treatments
On Jun. 15, 2020, the NIH announced it had launched a centralized, secure enclave to store and study…
Super-potent human antibodies protect against COVID-19 in animal tests
On Jun. 15, 2020, a team led by Scripps Research discovered antibodies in the blood of recovered COVID-19…
Mayo Clinic Study of Humanigen’s lenzilumab showed rapid recovery and discharged in severe and critical COVID-19 patients
On Jun. 15, 2020, Humanigen announced data on the first clinical use of lenzilumab in 12 COVID-19 patients….
McKesson to distribute COVID-19 vaccines in support of Operation Warp Speed
On Jun. 14, 2020, McKesson announced that it had expanded its existing partnership with the Centers for Disease…
AstraZeneca to supply Europe with up to 400 million doses of Oxford Universityﾒs vaccine at no profit
On Jun. 13, 2020, AstraZeneca announced an agreement with Europeﾒs Inclusive Vaccines Alliance (IVA), spearheaded by Germany, France,…
A cluster of COVID-19 in Beijing, People’s Republic of China was reported
On Jun. 13, 2020, officials from the WHO National Health Commission and Beijing Health Commission announced preliminary investigations…
Dr. Reddy’s Laboratories entered into a licensing agreement with Gilead Sciences for Remdesivir
On Jun. 13, 2020, Dr. Reddy’s Laboratories announced that it had entered into a non-exclusive Licensing Agreement with…
Sinovac announced positive preliminary results of phase I/II clinical trials for inactivated vaccine candidate against COVID-19
On Jun. 13, 2020, Sinovac Biotech announced positive preliminary results of phase I/II clinical trial for the Companyﾒs…
CIRM board approved two additional COVID-19 projects
On Jun. 12, 2020, the California Institute for Regenerative Medicine (CIRM) awarded $349,999 to Dr. Vaithilingaraja Arumugaswami at…
Cue Health received FDA EUA for Its rapid, portable, molecular point-of-care COVID-19 test
On Jun. 12, 2020, Cue Health announced that it had received Emergency Use Authorization from the U.S. Food…
Regeneron began first clinical trials of anti-viral antibody cocktail REGN-COV2 for treatment and prevention of COVID-19
On Jun. 11, 2020, Regeneron announced initiation of the first clinical trial of REGN-COV2, its investigational dual antibody…
Two science publications highlight potential of REGN-COV2 anti-viral antibody cocktail to protect against SARS-CoV-2 escape mutants
On Jun. 11, 2020, Regeneron announced that Science had accepted for publication two papers describing the creation of…
NIH researchers identified key genomic features that could differentiate SARS-CoV-2 from other coronaviruses that cause less severe disease
On Jun. 11, 2020, a team of researchers from the National Library of Medicine identified genomic features of…
Biotechnology | COVID-19 | WHO
WHO reported cluster of COVID-19 in Beijing, China
On Jun. 11, 2020, the World Trade Organizationﾒs (WTO) reported that it was following up with Chinese authorities…
Sinovac and Butantan joined efforts to advance clinical development of an inactivated vaccine for COVID-19 to phase III
On Jun. 11, 2020, Sinovac Biotech announced the signing of a clinical development collaboration agreement to advance the…
Emergent BioSolutions signed agreement to be US manufacturing partner for AstraZenecaﾒs COVID-19 vaccine candidate
On Jun. 11, 2020, Emergent BioSolutions announced deployment of its molecule-to-market contract development and manufacturing (CDMO) services to…
Biotechnology | COVID-19 | Diagnostics | FDA
InBios received FDA Emergency Use Authorization for COVID-19 antibody test
On Jun. 11, 2020, InBios announced that it had received Emergency Use Authorization (EUA) from the U.S. Food…
AIM ImmunoTech filed provisional patent application for ose of Ampligen(R) as potential therapy for COVID-19 Induced chronic fatigue
On Jun. 11, 2020, AIM ImmunoTech announced that it had filed a provisional patent application for, among other…
Atossa Therapeutics announced availability of manuscript on results from in vitro testing of COVID-19 drug
On Jun. 11, 2020, Atossa Therapeutics announced that the manuscript of the results from in vitro testing of…
Moderna advanced late-stage development of vaccine (mRNA-1273) against COVID-19
On Jun. 11, 2020, Moderna announced progress on late-stage development of mRNA-1273, the Company’s mRNA vaccine candidate against…
CHF Solutions publication highlights use of ultrafiltration for fluid management in COVID-19 patients
On Jun. 11, 2020, CHF Solutions announced that it has sold Aquadex SmartFlowﾙ consoles and disposables to a…
BioCryst’s galidesivir stops Zika viral replication in primate model
On Jun. 11, 2020, BioCryst Pharmaceuticals announced new data published in Science Translational Medicine that show, in a…